Lanzhou Foci Pharmaceutical Co Ltd Financial Flexibility Index
Lanzhou Foci Pharmaceutical Co Ltd financial flexibility index. Lanzhou Foci Pharmaceutical Co Ltd (002644) has a Financial Flexibility Index of 0.11x as of September 2025. Free cash flow of CN¥77.00 Million (operating CF CN¥75.62 Million minus capex CN¥1.38 Million) represents 0% of total liabilities (CN¥678.01 Million). See free cash flow generation of Lanzhou Foci Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Lanzhou Foci Pharmaceutical Co Ltd (2007–2024)
Financial flexibility index of Lanzhou Foci Pharmaceutical Co Ltd from 2007 to 2024. Historical Financial Flexibility Index trend for Lanzhou Foci Pharmaceutical Co Ltd across 18 annual periods. Check earnings quality score of Lanzhou Foci Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Lanzhou Foci Pharmaceutical Co Ltd Financial Flexibility Index by Year (2007–2024)
Lanzhou Foci Pharmaceutical Co Ltd financial flexibility index by year from 2007 to 2024. Year-by-year free cash flow to debt coverage for Lanzhou Foci Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Lanzhou Foci Pharmaceutical Co Ltd cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.08x | CN¥52.27 Million | CN¥38.98 Million | CN¥654.81 Million | ▼ -31.2% |
| 2023 | 0.12x | CN¥88.19 Million | CN¥65.71 Million | CN¥759.67 Million | ▼ -13.1% |
| 2022 | 0.13x | CN¥113.88 Million | CN¥72.37 Million | CN¥852.60 Million | ▲ +116.7% |
| 2021 | 0.06x | CN¥44.66 Million | CN¥11.85 Million | CN¥724.59 Million | ▼ -73.4% |
| 2020 | 0.23x | CN¥185.47 Million | CN¥62.89 Million | CN¥800.08 Million | ▲ +47.0% |
| 2019 | 0.16x | CN¥140.97 Million | CN¥47.82 Million | CN¥893.78 Million | ▼ -42.6% |
| 2018 | 0.27x | CN¥297.78 Million | CN¥36.66 Million | CN¥1.08 Billion | ▼ -46.5% |
| 2017 | 0.51x | CN¥509.19 Million | CN¥66.42 Million | CN¥990.68 Million | ▲ +18.4% |
| 2016 | 0.43x | CN¥323.90 Million | CN¥56.90 Million | CN¥746.13 Million | ▼ -51.8% |
| 2015 | 0.90x | CN¥116.03 Million | CN¥64.11 Million | CN¥128.77 Million | ▲ +97.5% |
| 2014 | 0.46x | CN¥142.11 Million | CN¥93.75 Million | CN¥311.40 Million | ▲ +21.0% |
| 2013 | 0.38x | CN¥75.34 Million | CN¥-10.47 Million | CN¥199.70 Million | ▼ -45.9% |
| 2012 | 0.70x | CN¥102.76 Million | CN¥-11.02 Million | CN¥147.38 Million | ▲ +74.6% |
| 2011 | 0.40x | CN¥72.35 Million | CN¥2.43 Million | CN¥181.14 Million | ▼ -33.6% |
| 2010 | 0.60x | CN¥78.03 Million | CN¥56.18 Million | CN¥129.70 Million | ▲ +280.5% |
| 2009 | 0.16x | CN¥26.74 Million | CN¥3.46 Million | CN¥169.09 Million | ▲ +315.4% |
| 2008 | 0.04x | CN¥6.99 Million | CN¥602.56K | CN¥183.70 Million | ▼ -97.1% |
| 2007 | 1.29x | CN¥213.16 Million | CN¥105.61 Million | CN¥164.72 Million | — |